Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...

Moleculin Biotech (NASDAQ:MBRX – Get Free Report) was downgraded by stock analysts at Maxim Group from a “buy” rating to a “hold” rating in a report issued on Wednesday, MarketBeat reports. Separately ...

Janney Montgomery Scott LLC lessened its holdings in Cerus Co. (NASDAQ:CERS – Free Report) by 11.6% in the 4th quarter, ...

Beijing’s action against clothing maker PVH and biotech company Illumina underlines risk created by trade tensions ...

Nano-X Imaging is a disruptive biotech investment. The AI push in the health sector is a long-term tailwind. See why we rate ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Concord Biotech tumbled 15.02% to Rs 1,793 after the company's consolidated net profit fell 2.1% to Rs 75.92 crore in Q3 FY25 as compared with Rs 77.57 crore in Q3 FY24.

The aggregate gross proceeds to the Company from the offering were approximately $1,050,000, before deducting the placement ...

Relay Therapeutics' financial stability is strong, but zero Q3 2024 revenue and rising net losses raise concerns. Find out ...

In connection with the offering, David Liu, a Senior Analyst at Velan Capital, was appointed to Edesa's Board of Directors, ...